News | May 11, 2024
Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
ORACEA is a trademark of Galderma Holdings, S.A.
The proposed facility is expected to be operational around January, 2027
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023
He is also inducted as a member of the management council and senior management personnel of the company
Subscribe To Our Newsletter & Stay Updated
